Noha M Bakr
Overview
Explore the profile of Noha M Bakr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bakr N, Hashim N, Ibrahim N, Saadawy S
Sci Rep
. 2025 Jan;
15(1):3872.
PMID: 39890883
Genetic factors play a significant role in the occurrence and clinical course of diabetic peripheral neuropathy (DPN). This research aimed to search the influence of adiponectin single nucleotide polymorphisms (SNPs)...
2.
Nassar A, Bakr N, Elyousefi E, Elkholy B, Fawzy M
J Cosmet Dermatol
. 2022 Aug;
21(11):6377-6384.
PMID: 35957511
Background: Psoriasis is a skin disorder mainly mediated by T helper (Th)-1 and Th-17 cells. Recently, high serum immunoglobulin (Ig)-E levels were detected in psoriatic patients. The etiopathogenesis of IgE...
3.
Nassar A, Nofal A, Bakr N, Essam R, Alakad R
J Cosmet Dermatol
. 2021 Dec;
21(9):3970-3978.
PMID: 34964227
Background: Candida antigen injection is one of the most widely used intralesional immunotherapy in the treatment of warts. It acts through the induction of systemic immune response. The pattern of...
4.
Nassar A, Alakad R, Essam R, Bakr N, Nofal A
J Am Acad Dermatol
. 2021 Aug;
87(2):419-421.
PMID: 34464624
No abstract available.
5.
Khalifa M, Bakr N, Ramadan A, Abd Elwahab K, Desoky E, Nageeb A, et al.
J Genet Eng Biotechnol
. 2021 Jun;
19(1):91.
PMID: 34152511
Background: Bladder cancer is considered heterogeneous diseases with two major subgroups: non-muscle- invasive bladder cancer (NMIBC) and muscle invasive bladder cancer (MIBC). It is a major healthcare problem, and it...
6.
Bakr N, Sayed Mahmoud M, Nabil R, Boushnak H, Swellam M
J Genet Eng Biotechnol
. 2021 Jun;
19(1):84.
PMID: 34089425
Background: Breast cancer (BC) is the common primary tumor among females. Hence, there is an urgent need to improve the early prediction and diagnosis of BC. For that reason, the...
7.
Bakr N, Hashim N, El-Baz H, Khalaf E, Elharoun A
Mult Scler Relat Disord
. 2020 Dec;
47:102654.
PMID: 33302229
Background: Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disorder of the central nervous system (CNS). It is immunologically induced in genetically susceptible individuals. Proinflammatory cytokines play an important...
8.
Emerging role of miRNAs as liquid biopsy markers for prediction of glioblastoma multiforme prognosis
Swellam M, Bakr N, El Magdoub H, Hamza M, El Arab L
J Mol Neurosci
. 2020 Sep;
71(4):836-844.
PMID: 32989634
Serum miRNAs (miRs) have gained consideration as encouraging molecular markers for cancer diagnosis and prediction of prognosis. The authors aimed to identify the exact role of miR-17-5p, miR-125b, and miR-221...
9.
Bakr N, Awad A, Moustafa E, El-Gebaly A
J Cell Biochem
. 2019 Jun;
120(10):18524-18532.
PMID: 31237020
Cancer prevalence is critically increasing worldwide; accordingly, improved prediction and therapeutic tools are necessary. Interleukin (IL)-21 is a potent antitumor cytokine, and the relationship between its gene variations and cancer...
10.
Swellam M, Ramadan A, El-Hussieny E, Bakr N, Hassan N, Sobeih M, et al.
J Cell Biochem
. 2019 Mar;
120(8):12321-12330.
PMID: 30825229
microRNAs (miRNAs) are implicated in carcinogenesis and their expression in biological fluids offer great potential as nucleic acid markers for cancer detection and progression. Authors investigated the expression level of...